China Likely To Delay Drug Price Cuts Until Next Year: Good News Or Bad?

SHANGHAI - The National Development and Reform Commission, China's leading economic regulatory body, is revising a drug price control plan that was issued in June for public feedback after receiving industry-led objections to some proposals